Blue Horseshoe Stocks: MBRX Blows its Lid

 
Kimberly Clark Corp. KMB

We want to kick things off this morning by highlighting the fantastic options idea we included in yesterday morning’s premarket report. That was the KMB Weekly $125-128 Calls, and we’re pleased to relay the stellar first-day performance of those contracts, all four of which produced enormous multibag intraday moves, including a thousand-percent-plus play in the $128′s.

$125 Calls – Range: 1.40-7.14  – Max Gain: 410%
$126 Calls – Range: 1.00-6.50 – Max Gain: 550%
$127 Calls – Range: .72-4.90  – Max Gain: 581%
$128 Calls – Range: .36-4.80  – Max Gain: 1233%
_____

FRESH OPTIONS IDEA:
Twitter, Inc. TWTR Weekly $35.50-37 Calls
Hasbro, Inc. HAS Weekly $97-101 Calls
Lockheed Martin Corp. LMT Weekly $327.50-$337.50 Calls


Moleculin Biotech, Inc. MBRX – Recap

Following the FDA fast-tracking of the company’s Annamycin drug, yesterday morning we noted that this stock we began tracking late last month had risen by 89% (.7772-1.47) right on the heels of the good news. It would appear that the development took some time to fully filter through the investment community, because even we weren’t prepared for the enormous continuation of momentum that has now transpired.

From yesterday’s 1.25 low-of-day, MBRX shot up like a rocket and ultimately reached a new peak of 3.15. That worked out to a single session surge of 152% From our initially observed low, it represents an increase of 305% in just over three weeks of trading. This has not turned out to be our biggest stock-only call of the year so far just yet, but it is right up there among the best.


Extended Watchlist:
TMPS, GNC, AYTU, HLTH, VERB, VTVT, FORK, WVE, RVP, CVM

Comments are closed.